Propranolol pharmacokinetics in infants treated for Infantile Hemangiomas requiring systemic therapy: Modeling and dosing regimen recommendations

Propranolol has become the first choice therapy for complicated Infantile Hemangiomas (IH). The pharmacokinetics of propranolol were evaluated after repeated oral administration of a new pediatric solution of propranolol at 3 mg kg(−1) day(−1) given twice daily (BID) in infants (77‐243 days) with IH...

Descripción completa

Detalles Bibliográficos
Autores principales: Del Frari, Laurence, Léauté‐Labrèze, Christine, Guibaud, Laurent, Barbarot, Sébastien, Lacour, Jean‐Philippe, Chaumont, Christine, Delarue, Alain, Voisard, Jean‐Jacques, Brunner, Valérie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925426/
https://www.ncbi.nlm.nih.gov/pubmed/29736244
http://dx.doi.org/10.1002/prp2.399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925426/
https://www.ncbi.nlm.nih.gov/pubmed/29736244
http://dx.doi.org/10.1002/prp2.399

Ejemplares similares